Antirheumatic AgentsArthritis, RheumatoidSulfasalazineHydroxychloroquineOrganogold CompoundsMethotrexateAuranofinIsoxazolesDrug Therapy, CombinationGold Sodium ThiomalateRheumatologySeverity of Illness IndexArthrographyPenicillamineFoot JointsRheumatoid FactorTreatment OutcomeJointsAnti-Inflammatory Agents, Non-SteroidalArthritis, PsoriaticReceptors, Tumor Necrosis FactorHand JointsUnited States Agency for Healthcare Research and QualityAntibodies, Monoclonal, HumanizedTumor Necrosis Factor-alphaArthritisRheumatic DiseasesAntibodies, MonoclonalSynovitisGlucocorticoidsPrednisoloneBiological ProductsBlood SedimentationAnti-Inflammatory AgentsArthritis, JuvenileProduct Surveillance, PostmarketingDisease ProgressionImmunoglobulin GSynovial MembraneSpondylitis, AnkylosingDouble-Blind MethodDrug Administration ScheduleOpportunistic InfectionsTreatment FailurePeptides, CyclicInterleukin 1 Receptor Antagonist ProteinImmunosuppressive AgentsRemission InductionEarly DiagnosisCohort StudiesFollow-Up StudiesImmunoconjugatesThiomalatesTime FactorsInjections, SubcutaneousClinical Trials as TopicDose-Response Relationship, DrugAdrenal Cortex HormonesProspective StudiesTripterygiumHealth StatusStatistics, NonparametricC-Reactive ProteinDisability EvaluationAutoantibodiesEpidemiologic MethodsPrednisonePhysician's Practice PatternsRandomized Controlled Trials as TopicAdministration, OralBiological MarkersRetrospective StudiesWrist JointLongitudinal StudiesUnited StatesRegistriesFinger JointPrognosisRisk FactorsLogistic ModelsPredictive Value of TestsReproducibility of ResultsImmunologic FactorsQuestionnairesGoldPlacebos